Top Markets
Coin of the day
Advicenne S.A. Advicenne S.A.

Advicenne S.A.

ALDVI
Rank in Stocks #28004
Advicenne S.A. operates as a specialized pharmaceutical firm, focusing on the... Advicenne S.A. operates as a specialized pharmaceutical firm, focusing on the innovation and commercialization of therapeutic solutions for various kidney-related disorders. The company's primary offering, Sibnayal, targets both distal renal tubular acidosis and cystinuria. Established in 2007, Advicenne S.A. maintains its principal offices in Paris, France.
Share Price
$2.00
Last synced: 2026-08-19
Market Cap
$29.13M
Change (1 day)
0.24%
Change (1 year)
38.57%
Country
FR
Trade Advicenne S.A. (ALDVI)

Category

EPS for Advicenne S.A. (ALDVI)
EPS as of 2026 TTM: 0
According to Advicenne S.A. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Advicenne S.A. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -
US
$-7.98 -
US
$27.74 -
NL
$2.98 -
AU
- -
CH